Skip to Main Content

Paper Details

Phase II study of stereotactic radiosurgery for the treatment of patients with oligoprogression on erlotinib.
Cancer Treat Res Commun
27
2019
Author NameAffiliation
Chad V PecotLineberger Cancer Center at the University of North Carolina
  • 1 - 1

Datasets

Release 1.2